Jordan vs Mali: Access to anti-retroviral drugs, male
Jordan
64.0%
in 2024
Mali
64.0%
in 2024
Jordan rank
87th
Mali rank
87th
Access to anti-retroviral drugs, male over time
- Jordan
- Mali
How they compare
Jordan currently reports 64.0% against 64.0% in Mali, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Jordan ahead.
Jordan ranks 87th and Mali ranks 87th of 141 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.6% | 6.3% | 14.3% | Jordan |
| 2010s | 42.9% | 25.5% | 17.4% | Jordan |
| 2020s | 53.8% | 49.4% | 4.4% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Jordan or Mali?
- Jordan, at 64.0% against 64.0% in Mali as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Jordan and Mali?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Mali?
- 25 years are reported by both, from 2000 to 2024.
- How do Jordan and Mali rank globally for access to anti-retroviral drugs, male?
- Jordan ranks 87th and Mali ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.